CCL2 and rheumatoid arthritis: Specifically, it is currently unknown whether SIA/anti-CCP ratios are correlated with B-cell Neu1 and ST6Gal1 levels and whether they effectively align with the two remission definitions and DAS28-MCP-1 criterion [14] in patients with RA.